Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study aims to describe hemodynamic effects of lower body negative pressure (LBNP).
20 healthy volunteers will be included. The study protocol consists of two parts.
LBNP is applied stepwise (20 mmHg increments). At each LBNP-level, after 2 min stabilization, blood flow in internal and external carotid arteries is measured. Thereafter, MSFP is measured. LBNP is applied to -80 mmHg, but terminated sooner if the subject experiences signs of decompensation.
Changes in cerebral StO2 will be related to relative changes in blood flow in the carotid arteries. After these measurements, blood flow to one arm will be occluded for 30 s. Venous pressure measured in an antecubital vein approximates MSFP. This will be related to volume status (LBNP-level and stroke volume reduction).
LBNP is applied stepwise (20 mmHg increments). At each LBNP-level, after 2 min stabilization, PEP and CPAP are applied at 0, 5 and 10 cmH20. LBNP is applied to -80 mmHg, but terminated sooner if the subject experiences signs of decompensation.
Flow in carotid arteries is measured by ultrasound/Doppler. Skin blood flow in the forehead measured by laser Doppler flowmetry and transcutaneous oxygen saturation.
If possible, blood flow velocity in a. cerebri media will be measured by transcranial Doppler.
Central venous pressure will be approximated by measuring pressure in the left subclavian vein ("half-way" catheter).
Cardiac stroke volume will be measured by suprasternal Doppler. Expiratory carbon dioxide (CO2) will be measured and recorded. Acral skin photoplethysmography performed using proprietary and custom-made photoplethysmographs.
Arterial blood pressure approximated by finger volume-clamp method.
The measurements above will be used for analyses of possible physiological mechanisms and post-hoc analyses.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lower body negative pressure | Experimental | Single-arm, lower body negative pressure, continuous positive airway pressure, positive expiratory pressure. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lower body negative pressure | Other | Model of hypovolemia: Lower body negative pressure down to -80 mmHg (maximum). |
|
| Measure | Description | Time Frame |
|---|---|---|
| StO2 (tissue oxygen saturation). | Association between cerebral StO2 and flow in a. carotis interna. | Approximatrly 30 min: From start LBNP (lower body negative pressure) exposure to 5 min after end LBNP. |
| Measure | Description | Time Frame |
|---|---|---|
| MSFP, mean systemic filling pressure (arm venous pressure during vascular occlusion). | Association between MSFP and volume status. | Approximatrly 30 min: From start LBNP (lower body negative pressure) exposure to 5 min after end LBNP. |
| Dynamic variables and PEP (positive expiratory pressure)/CPAP (continuous positive airway pressure) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Svein Aslak Landsverk, M.D., PhD | Oslo University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Oslo University Hospital | Oslo | Oslo | 0450 | Norway |
Not provided
| ID | Term |
|---|---|
| D020896 | Hypovolemia |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D008150 | Lower Body Negative Pressure |
| D045422 | Continuous Positive Airway Pressure |
| D011175 | Positive-Pressure Respiration |
| ID | Term |
|---|---|
| D003664 | Decompression |
| D013812 | Therapeutics |
| D012121 | Respiration, Artificial |
| D058109 | Airway Management |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Continuous positive airway pressure | Device | CPAP of 0, 5 and 10 cm water (H2O). |
|
|
| Positive expiratory pressure | Device | PEP of 0, 5 and 10 cm H2O. |
|
|
Association between dynamic variables during PEP/CPAP and volume status. Dynamic variables (variations in arterial pressure and photoplethysmographic waveforms with respiration) are calculated during with PEP and CPAP during hypovolemia (lower body negative pressure). |
| Approximatrly 30 min: From start LBNP (lower body negative pressure) exposure to 5 min after end LBNP. |
| D012138 |
| Respiratory Therapy |